The response of Escherichia coli to nalidixic acid was investigated by continuous turbidimetric monitoring of cultures exposed to the drug. Two distinct types of turbidimetric response were detected when dense populations of E. coli were exposed to nalidixic acid in a static system, but this difference was not found in low-inoculum experiments, nor in experiments in which initially dense inocula of E. coli were exposed to the drug in conditions similar to those encountered in the treatment of bacterial cystitis. Stable resistance to nalidixic acid was readily induced in cultures of E. coli. Such resistance emerged by a step-wise process and cultures could easily be converted to resistance to at least 64 μ g nalidixic acid per millilitre by sequential transfer. Resistance to drug levels greater than 64 μ g/ml was more difficult to induce and such variants were unstably resistant to the higher drug levels. ‘Wild’ nalidixic-acid-resistant E. coli were correspondingly found to be partially susceptible to concentrations of nalidixic acid exceeding 64 μ g/ml. Nalidixic acid resistance was even easier to induce in an in vitro model of the treatment of bacterial cystitis than in the static system, in that a single cycle of exposure to a ‘dose’ of the drug allowed the emergence of a population exhibiting a relatively high level of resistance. It is suggested that the therapeutic efficiency of nalidixic acid resides in a highly effective initial onslaught, and that, if infection is not controlled at this stage, the emergence of resistance is likely to be a cause of therapeutic failure.

Keywords:
Escherichia coli, Nalidixic acid, Bacterial resistance, Urinary tract infection, Turbidimetry
This content is only available via PDF.
© 1978 S. Karger AG, Basel
1978
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.